Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Avadel Pharmaceuticals Q3 EPS $0.00 Misses $0.07 Estimate, Sales $77.467M Beat $73.574M Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:37pm
Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.07 by 98.65 percent. This is a 103.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $77.467 million which beat the analyst consensus estimate of $73.574 million by 5.29 percent. This is a 54.86 percent increase over sales of $50.025 million the same period last year.

Posted In: AVDL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist